Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 19
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

MetaPhlAn 4 profiling of unknown species-level genome bins improves the characterization of diet-associated microbiome changes in mice

  • Manghi, Paolo
  • Vallès Colomer, Mireia
  • Segata, Nicola
Mouse models are key tools for investigating host-microbiome interactions. However, shotgun metagenomics can only profile a limited fraction of the mouse gut microbiome. Here, we employ a metagenomic profiling method, MetaPhlAn 4, which exploits a large catalog of metagenome-assembled genomes (including 22,718 metagenome-assembled genomes from mice) to improve the profiling of the mouse gut microbiome. We combine 622 samples from eight public datasets and an additional cohort of 97 mouse microbiomes, and we assess the potential of MetaPhlAn 4 to better identify diet-related changes in the host microbiome using a meta-analysis approach. We find multiple, strong, and reproducible diet-related microbial biomarkers, largely increasing those identifiable by other available methods relying only on reference information. The strongest drivers of the diet-induced changes are uncharacterized and previously undetected taxa, confirming the importance of adopting metagenomic methods integrating metagenomic assemblies for comprehensive profiling., The work was supported by the European Research Council (ERC-STG project MetaPG-716575 and ERC-CoG microTOUCH-101045015) to N.S. and ERC-CoG (project grant agreement no. 101001355) to O.K., by the European H2020 program (ONCOBIOME-825410 project and MASTER-818368 project) to N.S., by the National Cancer Institute of the National Institutes of Health (1U01CA230551) to N.S., by the Premio Internazionale Lombardia e Ricerca 2019 to N.S., by the European Research Council under the European Union’s Horizon 2020 Research and Innovation Programme (ERC-2016-StG-71577) to H.S., by VolkswagenStiftung’s initiative “Niedersächsisches Vorab” (grant no. 76251-99) to T.S, and by the European Research Council (CoG 865466) to T.S.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Large-scale metagenomic analysis of oral microbiomes reveals markers for autism spectrum disorders

  • Manghi, Paolo
  • Vallès Colomer, Mireia
  • Domenici, Enrico
The link between the oral microbiome and neurodevelopmental disorders remains a compelling hypothesis, still requiring confirmation in large-scale datasets. Leveraging over 7000 whole-genome sequenced salivary samples from 2025 US families with children diagnosed with autism spectrum disorders (ASD), our cross-sectional study shows that the oral microbiome composition can discriminate ASD subjects from neurotypical siblings (NTs, AUC = 0.66), with 108 differentiating species (q < 0.005). The relative abundance of these species is highly correlated with cognitive impairment as measured by Full-Scale Intelligence Quotient (IQ). ASD children with IQ < 70 also exhibit lower microbiome strain sharing with parents (p < 10-6) with respect to NTs. A two-pronged functional enrichment analysis suggests the contribution of enzymes from the serotonin, GABA, and dopamine degradation pathways to the distinct microbial community compositions observed between ASD and NT samples. Although measures of restrictive eating diet and proxies of oral hygiene show relatively minor effects on the microbiome composition, the observed associations with ASD and IQ may still represent unaccounted-for underlying differences in lifestyle among groups. While causal relationships could not be established, our study provides substantial support to the investigation of oral microbiome biomarkers in ASD., This work was supported by a grant from SFARI (Award 648614, E.D. and N.S.); by the European Research Council (ERC-STG project MetaPG-716575 and ERC-CoG project MicroTOUCH-101045015) to N.S.; by the European H2020 program (ONCOBIOME-825410 project and MASTER-818368 project) to N.S.; by the National Cancer Institute of the National Institutes of Health (1U01CA230551) to N.S.; by the Premio Internazionale Lombardia e Ricerca 2019 to N.S. We are grateful in particular to all of the families in SPARK, the SPARK clinical sites and SPARK staff. We appreciate obtaining access to the metagenomic raw data, the genetic data and the associated samples metadata on SFARI Base. The authors would like to thank Michael Whalen for his inspiring suggestion, which provided the starting point for this research. Approved researchers can obtain the SPARK population dataset described in this study (SFARI_SPARK_iWGS_v1.1) by applying at https://base.sfari.org.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Microbiome connections with host metabolism and habitual diet from 1,098 deeply phenotyped individuals

  • Asnicar, Francesco
  • Vallès Colomer, Mireia
  • Segata, Nicola
The gut microbiome is shaped by diet and influences host metabolism; however, these links are complex and can be unique to each individual. We performed deep metagenomic sequencing of 1,203 gut microbiomes from 1,098 individuals enrolled in the Personalised Responses to Dietary Composition Trial (PREDICT 1) study, whose detailed long-term diet information, as well as hundreds of fasting and same-meal postprandial cardiometabolic blood marker measurements were available. We found many significant associations between microbes and specific nutrients, foods, food groups and general dietary indices, which were driven especially by the presence and diversity of healthy and plant-based foods. Microbial biomarkers of obesity were reproducible across external publicly available cohorts and in agreement with circulating blood metabolites that are indicators of cardiovascular disease risk. While some microbes, such as Prevotella copri and Blastocystis spp., were indicators of favorable postprandial glucose metabolism, overall microbiome composition was predictive for a large panel of cardiometabolic blood markers including fasting and postprandial glycemic, lipemic and inflammatory indices. The panel of intestinal species associated with healthy dietary habits overlapped with those associated with favorable cardiometabolic and postprandial markers, indicating that our large-scale resource can potentially stratify the gut microbiome into generalizable health levels in individuals without clinically manifest disease., This work was supported by Zoe Global and received support from grants from the Wellcome Trust (no. 212904/Z/18/Z) and Medical Research Council/British Heart Foundation Ancestry and Biological Informative Markers for Stratification of Hypertension (no. MR/M016560/1). The work was also supported by the European Research Council (ERC-STG project MetaPG-716575 to N.S.), MIUR ‘Futuro in Ricerca’ (grant no. RBFR13EWWI_001 to N.S.), the European H2020 program (ONCOBIOME-825410 and MASTER-818368 projects to N.S.), the National Cancer Institute of the National Institutes of Health (grant no. 1U01CA230551 to N.S.) and the Premio Internazionale Lombardia e Ricerca 2019 to N.S. S.E.B. was supported in part by a grant funded by the Biotechnology and Biological Sciences Research Council (grant no. BB/NO12739/1). P.W.F. was supported in part by grants from the European Research Council (grant no. CoG-2015_681742_NASCENT), Swedish Research Council (grant no. IRC15-0067) and Novo Nordisk Foundation. A.T.C. was supported in part as a Stuart and Suzanne Steele MGH Research Scholar. TwinsUK is funded by the Wellcome Trust, Medical Research Council, European Union, Chronic Disease Research Foundation, Zoe Global and the National Institute for Health Research-funded BioResource, Clinical Research Facility and Biomedical Research Centre based at Guy’s and St Thomas’ NHS Foundation Trust in partnership with King’s College London.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Birthmode and environment-dependent microbiota transmission dynamics are complemented by breastfeeding during the first year

  • Selma Royo, Marta
  • Dubois, Léonard
  • Manara, Serena
  • Armanini, Federica
  • Cabrera Rubio, Raúl
  • Vallès Colomer, Mireia
  • González, Sonia
  • Parra Llorca, Anna
  • Escuriet Peiró, Ramón, 1968-
  • Bode, Lars
  • Martínez Costa, Cecilia
  • Segata, Nicola
  • Collado, María Carmen
The composition and maturation of the early-life microbiota are modulated by a number of perinatal factors, whose interplay in relation to microbial vertical transmission remains inadequately elucidated. Using recent strain-tracking methodologies, we analyzed mother-to-infant microbiota transmission in two different birth environments: hospital-born (vaginal/cesarean) and home-born (vaginal) infants and their mothers. While delivery mode primarily explains initial compositional differences, place of birth impacts transmission timing-being early in homebirths and delayed in cesarean deliveries. Transmission patterns vary greatly across species and birth groups, yet certain species, like Bifidobacterium longum, are consistently vertically transmitted regardless of delivery setting. Strain-level analysis of B. longum highlights relevant and consistent subspecies replacement patterns mainly explained by breastfeeding practices, which drive changes in human milk oligosaccharide (HMO) degrading capabilities. Our findings highlight how delivery setting, breastfeeding duration, and other lifestyle preferences collectively shape vertical transmission, impacting infant gut colonization during early life., We would like to thank the Biobank (Biobanco para la Investigación Biomédica y en Salud Pública de la Comunidad Valenciana, IBSP-CV) for their work in processing the biological samples. The MAMI team would like to acknowledge the support from H2020-ERC Starting Grant (MAMI-639226 project) and from Spanish Ministry of Science and Innovation (MCIN) research grant (ref. PID2022-139475OB-I00). R.C.-R. thanks Generalitat Valenciana for the grant Plan GenT project (CDEIGENT 2020). M.C.C., M.-S.R., and R.C.-R. would also like to acknowledge the award of the Spanish Government MCIN/AEI to the Institute of Agrochemistry and Food Technology (IATA-CSIC) as Centre of Excellence Severo Ochoa (CEX2021-001189-S MCIN/AEI/10.13039/ 501100011033). This work was also supported by the European Research Council (ERC-STG project MetaPG-716575 and ERC-CoG microTOUCH-101045015) to N.S., by the European H2020 programme (ONCOBIOME-825410 project, MASTER-818368 project, and IHMCSA-964590) to N.S., by the National Cancer Institute of the National Institutes of Health (1U01CA230551) to N.S., and by EMBO ALTF 593–2020 to M.V.-C.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Paternal and induced gut microbiota seeding complement mother-to-infant transmission

  • Dubois, Léonard
  • Vallès Colomer, Mireia
  • Ponsero, Alise
  • Helve, Otto
  • Andersson, Sture
  • Kolho, Kaija-Leena
  • Asnicar, Francesco
  • Korpela, Katri
  • Salonen, Anne
  • Segata, Nicola
  • Vos, Willem M. de
Microbial colonization of the neonatal gut involves maternal seeding, which is partially disrupted in cesarean-born infants and after intrapartum antibiotic prophylaxis. However, other physically close individuals could complement such seeding. To assess the role of both parents and of induced seeding, we analyzed two longitudinal metagenomic datasets (health and early life microbiota [HELMi]: N = 74 infants, 398 samples, and SECFLOR: N = 7 infants, 35 samples) with cesarean-born infants who received maternal fecal microbiota transplantation (FMT). We found that the father constitutes a stable source of strains for the infant independently of the delivery mode, with the cumulative contribution becoming comparable to that of the mother after 1 year. Maternal FMT increased mother-infant strain sharing in cesarean-born infants, raising the average bacterial empirical growth rate while reducing pathogen colonization. Overall, our results indicate that maternal seeding is partly complemented by that of the father and support the potential of induced seeding to restore potential deviations in this process., This work was partially supported by the Netherlands Organization for Scientific Research (NWO-SIAM gravitation grant 024.002.002) to W.M.d.V., Business Finland (grant 329/31/2015) to W.M.d.V. and A.S., the Academy of Finland (grants 339172 to A.J.P. and 1325103 to A.S.), the European Research Council (ERC-StG project MetaPG-716575 and ERC-CoG microTOUCH-101045015) to N.S., and EMBO ALTF 593–2020 to M.V.-C. The work was also partially supported by the European H2020 programme (ONCOBIOME-825410 project, MASTER-818368 project, and IHMCSA-964590) to N.S., by the National Cancer Institute of the National Institutes of Health (1U01CA230551) to N.S., and by the Premio Internazionale Lombardia e Ricerca 2019 to N.S. Open access funded by the Helsinki University Library.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Neuroblastoma is associated with alterations in gut microbiome composition subsequent to maternal microbial seeding

  • Vallès Colomer, Mireia
  • Manghi, Paolo
  • Cumbo, Fabio
  • Masetti, Giulia
  • Armanini, Federica
  • Asnicar, Francesco
  • Blanco-Míguez, Aitor
  • Pinto, Federica
  • Punčochář, Michal
  • Garaventa, Alberto
  • Amoroso, Loredana
  • Ponzoni, Mirco
  • Corrias, Maria Valeria
  • Segata, Nicola
Background: Neuroblastoma is the most frequent extracranial solid tumour in children, accounting for ∼15% of deaths due to cancer in childhood. The most common clinical presentation are abdominal tumours. An altered gut microbiome composition has been linked to multiple cancer types, and reported in murine models of neuroblastoma. Whether children with neuroblastoma display alterations in gut microbiome composition remains unexplored. Methods: We assessed gut microbiome composition by shotgun metagenomic profiling in an observational cross-sectional study on 288 individuals, consisting of patients with a diagnosis of neuroblastoma at disease onset (N = 63), healthy controls matching the patients on the main covariates of microbiome composition (N = 94), healthy siblings of the patients (N = 13), mothers of patients (N = 59), and mothers of the controls (N = 59). We examined taxonomic and functional microbiome composition and mother-infant strain transmission patterns. Findings: Patients with neuroblastoma displayed alterations in gut microbiome composition characterised by reduced microbiome richness, decreased relative abundances of 18 species (including Phocaeicola dorei and Bifidobacterium bifidum), enriched protein fermentation and reduced carbohydrate fermentation potential. Using machine learning, we could successfully discriminate patients from controls (AUC = 82%). Healthy siblings did not display such alterations but resembled the healthy control group. No significant differences in maternal microbiome composition nor mother-to-offspring transmission were detected. Interpretation: Patients with neuroblastoma display alterations in taxonomic and functional gut microbiome composition, which cannot be traced to differential maternal seeding. Follow-up research should include investigating potential causal links., This study was funded by the Italian Ministry of Health Ricerca Corrente and Ricerca Finalizzata 5 per mille (to MPonzoni); Fondazione Italiana Neuroblastoma (to MPonzoni); European Research Council (ERC-StG project MetaPG-716575 and ERC-CoG microTOUCH-101045015 to NS); the European H2020 program ONCOBIOME-825410 project (to NS); the National Cancer Institute of the National Institutes of Health 1U01CA230551 (to NS); the Premio Internazionale Lombardia e Ricerca 2019 (to NS); the MIUR Progetti di Ricerca di Rilevante Interesse Nazionale (PRIN) Bando 2017 Grant 2017J3E2W2 (to NS); EMBO ALTF 593-2020 and Knowledge Generation Project from the Spanish Ministry of Science and Innovation (PID2022-139328OA-I00) (to MV-C).
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Intestinal Blastocystis is linked to healthier diets and more favorable cardiometabolic outcomes in 56,989 individuals from 32 countries

  • Piperni, Elisa
  • Vallès Colomer, Mireia
  • Asnicar, Francesco
Diet impacts human health, influencing body adiposity and the risk of developing cardiometabolic diseases. The gut microbiome is a key player in the diet-health axis, but while its bacterial fraction is widely studied, the role of micro-eukaryotes, including Blastocystis, is underexplored. We performed a global-scale analysis on 56,989 metagenomes and showed that human Blastocystis exhibits distinct prevalence patterns linked to geography, lifestyle, and dietary habits. Blastocystis presence defined a specific bacterial signature and was positively associated with more favorable cardiometabolic profiles and negatively with obesity (p < 1e-16) and disorders linked to altered gut ecology (p < 1e-8). In a diet intervention study involving 1,124 individuals, improvements in dietary quality were linked to weight loss and increases in Blastocystis prevalence (p = 0.003) and abundance (p < 1e-7). Our findings suggest a potentially beneficial role for Blastocystis, which may help explain personalized host responses to diet and downstream disease etiopathogenesis., We thank the participants of the PREDICT program. This work was supported by Zoe Ltd. and TwinsUK, which are funded by the Wellcome Trust, Medical Research Council, Versus Arthritis, European Union Horizon 2020, Chronic Disease Research Foundation, the National Institute for Health Research Clinical Research Network, and the Biomedical Research Centre based at Guy’s and St Thomas’ NHS Foundation Trust in partnership with King’s College London. It was partially supported by the American Gastroenterological Association Research Foundation’s Research Scholars Award to L.H.N., the Crohn’s and Colitis Foundation Career Development Award to L.H.N., and NIH/NIDDK K23DK125838 to L.H.N. L.H.N. is the Massachusetts General Hospital/Chen Institute Transformative Scholar in Medicine. The study was supported by the European Research Council (ERC-STG project MetaPG-716575 and ERC-CoG microTOUCH-101045015) to N.S., by the European Union’s Horizon 2020 program (ONCOBIOME-825410 project, MASTER- 818368 project, and IHMCSA-964590) to N.S., by the European Union’s Horizon Europe program (DOMINO-101060218), by the European Union NextGenerationEU (INEST) to N.S., by the National Cancer Institute of the National Institutes of Health (1U01CA230551) to N.S. and R35 CA253178 to A.T.C., and by the Premio Internazionale Lombardia e Ricerca 2019 to N.S. The MBS and MLVS were supported by NIH U01CA176726 and U01CA167552. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The Lifelines Biobank initiative has been made possible by the Dutch Ministry of Health, Welfare, and Sport; the Dutch Ministry of Economic Affairs; the University Medical Center Groningen; the University of Groningen; and the Northern Provinces of the Netherlands. The authors acknowledge the services of the Lifelines Cohort Study, the contributing research centers delivering data to Lifelines, and all the study participants. J.F. is supported by the Dutch Heart Foundation IN-CONTROL (CVON2018-27), the ERC-CoG (No.101001678), NWO-VICI grant VI.C.202.022, the AMMODO Science Award 2023 for Biomedical Sciences from Stichting Ammodo, and the Netherlands Organ-on-Chip Initiative, an NWO Gravitation project (024.003.001) funded by the Ministry of Education, Culture, and Science of The Netherlands. A.Z. is supported by the Dutch Heart Foundation IN-CONTROL (CVON2018-27), the ERC-StG (No. 715772), NWO-VIDI grant 016.178.056, and the NWO Gravitation grant Exposome-NL (024.004.017). A.T.C. is partially supported by an American Cancer Society Research Professor Award.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Coffee consumption is associated with intestinal Lawsonibacter asaccharolyticus abundance and prevalence across multiple cohorts

  • Manghi, Paolo
  • Vallès Colomer, Mireia
  • Song, Mingyang
Although diet is a substantial determinant of the human gut microbiome, the interplay between specific foods and microbial community structure remains poorly understood. Coffee is a habitually consumed beverage with established metabolic and health benefits. We previously found that coffee is, among >150 items, the food showing the highest correlation with microbiome components. Here we conducted a multi-cohort, multi-omic analysis of US and UK populations with detailed dietary information from a total of 22,867 participants, which we then integrated with public data from 211 cohorts (N = 54,198). The link between coffee consumption and microbiome was highly reproducible across different populations (area under the curve of 0.89), largely driven by the presence and abundance of the species Lawsonibacter asaccharolyticus. Using in vitro experiments, we show that coffee can stimulate growth of L. asaccharolyticus. Plasma metabolomics on 438 samples identified several metabolites enriched among coffee consumers, with quinic acid and its potential derivatives associated with coffee and L. asaccharolyticus. This study reveals a metabolic link between a specific gut microorganism and a specific food item, providing a framework for the understanding of microbial dietary responses at the biochemical level., This work was supported by ZOE and TwinsUK, which is funded by the Wellcome Trust, Medical Research Council, Versus Arthritis, European Union Horizon 2020, Chronic Disease Research Foundation, the National Institute for Health Research Clinical Research Network and Biomedical Research Centre based at Guy’s and St Thomas’ NHS Foundation Trust in partnership with King’s College London. We acknowledge the support of the European Research Council (ERC-STG project MetaPG-716575 and ERC-CoG microTOUCH-101045015) to N.S., of the European Union’s Horizon 2020 programme (ONCOBIOME-825410 project, MASTER-818368 project and IHMCSA-964590) to N.S., of the MUR PNRR project INEST-Interconnected Nord-Est Innovation Ecosystem (ECS00000043) funded by the NextGenerationEU to N.S., and of the National Cancer Institute of the National Institutes of Health (1U01CA230551 to N.S. and U01CA261961 and R01CA263776 to M.S.) and of the Premio Internazionale Lombardia e Ricerca 2019 to N.S. The MBS and MLVS were supported by NIH U01CA176726 and U01CA167552. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Mother-to-Infant Microbial Transmission from Different Body Sites Shapes the Developing Infant Gut Microbiome

  • Ferretti, Pamela
  • Pasolli, Edoardo
  • Tett, Adrian
  • Asnicar, Francesco
  • Gorfer, Valentina
  • Fedi, Sabina
  • Armanini, Federica
  • Truong, Duy Tin
  • Manara, Serena
  • Zolfo, Moreno
  • Beghini, Francesco
  • Bertorelli, Roberto
  • de Sanctis, Veronica
  • Bariletti, Ilaria
  • Canto, Rosarita
  • Clementi,Rosanna
  • Cologna,Marina
  • Crifò, Tiziana
  • Cusumano, Giuseppina
  • Gottardi, Stefania
  • Innamorati, Claudia
  • Masè,Caterina
  • Postai,Daniela
  • Savoi, Daniela
  • Duranti, Sabrina
  • Lugli, Gabriele Andrea
  • Mancabelli, Leonardo
  • Turroni, Francesca
  • Ferrario, Chiara
  • Milani, Christian
  • Mangifesta, Marta
  • Anzalone, Rosaria
  • Viappiani, Alice
  • Yassour, Moran
  • Vlamakis, Hera
  • Xavier, Ramnik
  • Collado, María Carmen
  • Koren,Omry
  • Tateo, Saverio
  • Soffiati,Massimo
  • Pedrotti, Anna
  • Ventura, Marco
  • Huttenhower, Curtis
  • Bork, Peer
  • Segata, Nicola
The acquisition and development of the infant microbiome are key to establishing a healthy host-microbiome symbiosis. The maternal microbial reservoir is thought to play a crucial role in this process. However, the source and transmission routes of the infant pioneering microbes are poorly understood. To address this, we longitudinally sampled the microbiome of 25 mother-infant pairs across multiple body sites from birth up to 4 months postpartum. Strain-level metagenomic profiling showed a rapid influx of microbes at birth followed by strong selection during the first few days of life. Maternal skin and vaginal strains colonize only transiently, and the infant continues to acquire microbes from distinct maternal sources after birth. Maternal gut strains proved more persistent in the infant gut and ecologically better adapted than those acquired from other sources. Together, these data describe the mother-to-infant microbiome transmission routes that are integral in the development of the infant microbiome., his study was supported by Fondazione CARITRO fellowship Rif. Int. 2013.0239 to N.S. The work was also partially supported by the European Research Council (ERC-STG project MetaPG-716575), MIUR “Futuro in Ricerca” RBFR13EWWI_001, the People Program (Marie Curie Actions) of the European Union Seventh Framework Program (FP7/2007–2013) under REA grant agreement no. PCIG13-GA-2013-618833, the LEO Pharma Foundation to N.S., and a European Union H2020 Marie-Curie grant (707345) to E.P., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

The Prevotella copri Complex Comprises Four Distinct Clades Underrepresented in Westernized Populations

  • Tett, Adrian
  • Huang, Kun D.
  • Asnicar, Francesco
  • Fehlner-Peach, Hannah
  • Pasolli, Edoardo
  • Karcher, Nicolai
  • Armanini, Federica
  • Manghi, Paolo
  • Bonham, Kevin
  • Zolfo, Moreno
  • De Filippis, Francesca
  • Magnabosco, Cara
  • Bonneau, Richard
  • Lusingu, John
  • Amuasi, John
  • Reinhard, Karl
  • Rattei, Thomas
  • Boulund, Fredrik
  • Engstrand, Lars
  • Zink, Albert
  • Collado, María Carmen
  • Littman, Dan R.
  • Eibach, Daniel
  • Ercolini, Danilo
  • Rota-Stabelli, Omar
  • Huttenhower, Curtis
  • Maixner, Frank
  • Segata, Nicola
Prevotella copri is a common human gut microbe that has been both positively and negatively associated with host health. In a cross-continent meta-analysis exploiting >6,500 metagenomes, we obtained >1,000 genomes and explored the genetic and population structure of P. copri. P. copri encompasses four distinct clades (>10% inter-clade genetic divergence) that we propose constitute the P. copri complex, and all clades were confirmed by isolate sequencing. These clades are nearly ubiquitous and co-present in non-Westernized populations. Genomic analysis showed substantial functional diversity in the complex with notable differences in carbohydrate metabolism, suggesting that multi-generational dietary modifications may be driving reduced prevalence in Westernized populations. Analysis of ancient metagenomes highlighted patterns of P. copri presence consistent with modern non-Westernized populations and a clade delineation time pre-dating human migratory waves out of Africa. These findings reveal that P. copri exhibits a high diversity that is underrepresented in Western-lifestyle populations., This project has received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (grant agreement No 716575) to N.S. This work was also supported by the NIH NHGRI grant R01HG005220, the NIDDK grant R24DK110499, the NIDDK grant U54DE023798, and the CMIT grant 6935956 to C.H.; the NYU-HHC CTSI grant (1TL1TR001447) to H.F.P.; the US National Institute of Health grant R01-DK103358-01 to R.B. and D.R.L.; the Howard Hughes Medical Institute to D.R.L.; and the MIUR “Futuro in Ricerca” RBFR13EWWI_001, the European Union (H2020-SFS-2018-1 project MASTER-818368 and H2020-SC1-BHC project ONCOBIOME-825410) to N.S. Further support was provided by the Programma Ricerca Budget Eurac 2017 of the Province of Bolzano, Italy to F.M., and by the EU-H2020 (DiMeTrack-707345) to E.P. and N.S., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Birthmode and environment-dependent microbiota transmission dynamics are complemented by breastfeeding during the first year

  • Selma Royo, Marta
  • Dubois, Léonard
  • Manara, Serena
  • Armanini, Federica
  • Cabrera-Rubio, Raúl
  • Valles-Colomer, Mireia
  • González, Sonia
  • Parra Llorca, Anna
  • Escuriet, Ramon
  • Bode, Lars
  • Martínez Costa, Cecilia
  • Segata, Nicola
  • Collado, María Carmen
The composition and maturation of the early-life microbiota are modulated by a number of perinatal factors, whose interplay in relation to microbial vertical transmission remains inadequately elucidated. Using recent strain-tracking methodologies, we analyzed mother-to-infant microbiota transmission in two different birth environments: hospital-born (vaginal/cesarean) and home-born (vaginal) infants and their mothers. While delivery mode primarily explains initial compositional differences, place of birth impacts transmission timing-being early in homebirths and delayed in cesarean deliveries. Transmission patterns vary greatly across species and birth groups, yet certain species, like Bifidobacterium longum, are consistently vertically transmitted regardless of delivery setting. Strain-level analysis of B. longum highlights relevant and consistent subspecies replacement patterns mainly explained by breastfeeding practices, which drive changes in human milk oligosaccharide (HMO) degrading capabilities. Our findings highlight how delivery setting, breastfeeding duration, and other lifestyle preferences collectively shape vertical transmission, impacting infant gut colonization during early life., The MAMI team would like to acknowledge the support from H2020-ERC Starting Grant (MAMI-639226 project) and from Spanish Ministry of Science and Innovation (MCIN) research grant (ref. PID2022-139475OB-I00). R.C.-R. thanks Generalitat Valenciana for the grant Plan GenT project (CDEIGENT 2020). M.C.C., M.-S.R., and R.C.-R. would also like to acknowledge the award of the Spanish Government MCIN/AEI to the Institute of Agrochemistry and Food Technology (IATA-CSIC) as Centre of Excellence Severo Ochoa (CEX2021-001189-S MCIN/AEI/10.13039/ 501100011033). This work was also supported by the European Research Council (ERC-STG project MetaPG-716575 and ERC-CoG microTOUCH-101045015) to N.S., by the European H2020 programme (ONCOBIOME-825410 project, MASTER-818368 project, and IHMCSA-964590) to N.S., by the National Cancer Institute of the National Institutes of Health (1U01CA230551) to N.S., and by EMBO ALTF 593–2020 to M.V.-C., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX 2021-001189-S), Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Birthmode and environment-dependent microbiota transmission dynamics are complemented by breastfeeding during the first year

  • Selma Royo, Marta
  • Dubois, Léonard
  • Manara, Serena
  • Armanini, Federica
  • Cabrera Rubio, Raúl
  • Vallès Colomer, Mireia
  • González, Sonia
  • Parra Llorca, Anna
  • Escuriet Peiró, Ramón, 1968-
  • Bode, Lars
  • Martínez Costa, Cecilia
  • Segata, Nicola
  • Collado, María Carmen
The composition and maturation of the early-life microbiota are modulated by a number of perinatal factors, whose interplay in relation to microbial vertical transmission remains inadequately elucidated. Using recent strain-tracking methodologies, we analyzed mother-to-infant microbiota transmission in two different birth environments: hospital-born (vaginal/cesarean) and home-born (vaginal) infants and their mothers. While delivery mode primarily explains initial compositional differences, place of birth impacts transmission timing-being early in homebirths and delayed in cesarean deliveries. Transmission patterns vary greatly across species and birth groups, yet certain species, like Bifidobacterium longum, are consistently vertically transmitted regardless of delivery setting. Strain-level analysis of B. longum highlights relevant and consistent subspecies replacement patterns mainly explained by breastfeeding practices, which drive changes in human milk oligosaccharide (HMO) degrading capabilities. Our findings highlight how delivery setting, breastfeeding duration, and other lifestyle preferences collectively shape vertical transmission, impacting infant gut colonization during early life., We would like to thank the Biobank (Biobanco para la Investigación Biomédica y en Salud Pública de la Comunidad Valenciana, IBSP-CV) for their work in processing the biological samples. The MAMI team would like to acknowledge the support from H2020-ERC Starting Grant (MAMI-639226 project) and from Spanish Ministry of Science and Innovation (MCIN) research grant (ref. PID2022-139475OB-I00). R.C.-R. thanks Generalitat Valenciana for the grant Plan GenT project (CDEIGENT 2020). M.C.C., M.-S.R., and R.C.-R. would also like to acknowledge the award of the Spanish Government MCIN/AEI to the Institute of Agrochemistry and Food Technology (IATA-CSIC) as Centre of Excellence Severo Ochoa (CEX2021-001189-S MCIN/AEI/10.13039/ 501100011033). This work was also supported by the European Research Council (ERC-STG project MetaPG-716575 and ERC-CoG microTOUCH-101045015) to N.S., by the European H2020 programme (ONCOBIOME-825410 project, MASTER-818368 project, and IHMCSA-964590) to N.S., by the National Cancer Institute of the National Institutes of Health (1U01CA230551) to N.S., and by EMBO ALTF 593–2020 to M.V.-C.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Neuroblastoma is associated with alterations in gut microbiome composition subsequent to maternal microbial seeding

  • Vallès Colomer, Mireia
  • Manghi, Paolo
  • Cumbo, Fabio
  • Masetti, Giulia
  • Armanini, Federica
  • Asnicar, Francesco
  • Blanco-Míguez, Aitor
  • Pinto, Federica
  • Punčochář, Michal
  • Garaventa, Alberto
  • Amoroso, Loredana
  • Ponzoni, Mirco
  • Corrias, Maria Valeria
  • Segata, Nicola
Background: Neuroblastoma is the most frequent extracranial solid tumour in children, accounting for ∼15% of deaths due to cancer in childhood. The most common clinical presentation are abdominal tumours. An altered gut microbiome composition has been linked to multiple cancer types, and reported in murine models of neuroblastoma. Whether children with neuroblastoma display alterations in gut microbiome composition remains unexplored. Methods: We assessed gut microbiome composition by shotgun metagenomic profiling in an observational cross-sectional study on 288 individuals, consisting of patients with a diagnosis of neuroblastoma at disease onset (N = 63), healthy controls matching the patients on the main covariates of microbiome composition (N = 94), healthy siblings of the patients (N = 13), mothers of patients (N = 59), and mothers of the controls (N = 59). We examined taxonomic and functional microbiome composition and mother-infant strain transmission patterns. Findings: Patients with neuroblastoma displayed alterations in gut microbiome composition characterised by reduced microbiome richness, decreased relative abundances of 18 species (including Phocaeicola dorei and Bifidobacterium bifidum), enriched protein fermentation and reduced carbohydrate fermentation potential. Using machine learning, we could successfully discriminate patients from controls (AUC = 82%). Healthy siblings did not display such alterations but resembled the healthy control group. No significant differences in maternal microbiome composition nor mother-to-offspring transmission were detected. Interpretation: Patients with neuroblastoma display alterations in taxonomic and functional gut microbiome composition, which cannot be traced to differential maternal seeding. Follow-up research should include investigating potential causal links., This study was funded by the Italian Ministry of Health Ricerca Corrente and Ricerca Finalizzata 5 per mille (to MPonzoni); Fondazione Italiana Neuroblastoma (to MPonzoni); European Research Council (ERC-StG project MetaPG-716575 and ERC-CoG microTOUCH-101045015 to NS); the European H2020 program ONCOBIOME-825410 project (to NS); the National Cancer Institute of the National Institutes of Health 1U01CA230551 (to NS); the Premio Internazionale Lombardia e Ricerca 2019 (to NS); the MIUR Progetti di Ricerca di Rilevante Interesse Nazionale (PRIN) Bando 2017 Grant 2017J3E2W2 (to NS); EMBO ALTF 593-2020 and Knowledge Generation Project from the Spanish Ministry of Science and Innovation (PID2022-139328OA-I00) (to MV-C).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Paternal and induced gut microbiota seeding complement mother-to-infant transmission

  • Dubois, Léonard
  • Vallès Colomer, Mireia
  • Ponsero, Alise
  • Helve, Otto
  • Andersson, Sture
  • Kolho, Kaija-Leena
  • Asnicar, Francesco
  • Korpela, Katri
  • Salonen, Anne
  • Segata, Nicola
  • Vos, Willem M. de
Microbial colonization of the neonatal gut involves maternal seeding, which is partially disrupted in cesarean-born infants and after intrapartum antibiotic prophylaxis. However, other physically close individuals could complement such seeding. To assess the role of both parents and of induced seeding, we analyzed two longitudinal metagenomic datasets (health and early life microbiota [HELMi]: N = 74 infants, 398 samples, and SECFLOR: N = 7 infants, 35 samples) with cesarean-born infants who received maternal fecal microbiota transplantation (FMT). We found that the father constitutes a stable source of strains for the infant independently of the delivery mode, with the cumulative contribution becoming comparable to that of the mother after 1 year. Maternal FMT increased mother-infant strain sharing in cesarean-born infants, raising the average bacterial empirical growth rate while reducing pathogen colonization. Overall, our results indicate that maternal seeding is partly complemented by that of the father and support the potential of induced seeding to restore potential deviations in this process., This work was partially supported by the Netherlands Organization for Scientific Research (NWO-SIAM gravitation grant 024.002.002) to W.M.d.V., Business Finland (grant 329/31/2015) to W.M.d.V. and A.S., the Academy of Finland (grants 339172 to A.J.P. and 1325103 to A.S.), the European Research Council (ERC-StG project MetaPG-716575 and ERC-CoG microTOUCH-101045015) to N.S., and EMBO ALTF 593–2020 to M.V.-C. The work was also partially supported by the European H2020 programme (ONCOBIOME-825410 project, MASTER-818368 project, and IHMCSA-964590) to N.S., by the National Cancer Institute of the National Institutes of Health (1U01CA230551) to N.S., and by the Premio Internazionale Lombardia e Ricerca 2019 to N.S. Open access funded by the Helsinki University Library.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

MetaPhlAn 4 profiling of unknown species-level genome bins improves the characterization of diet-associated microbiome changes in mice

  • Manghi, Paolo
  • Vallès Colomer, Mireia
  • Segata, Nicola
Mouse models are key tools for investigating host-microbiome interactions. However, shotgun metagenomics can only profile a limited fraction of the mouse gut microbiome. Here, we employ a metagenomic profiling method, MetaPhlAn 4, which exploits a large catalog of metagenome-assembled genomes (including 22,718 metagenome-assembled genomes from mice) to improve the profiling of the mouse gut microbiome. We combine 622 samples from eight public datasets and an additional cohort of 97 mouse microbiomes, and we assess the potential of MetaPhlAn 4 to better identify diet-related changes in the host microbiome using a meta-analysis approach. We find multiple, strong, and reproducible diet-related microbial biomarkers, largely increasing those identifiable by other available methods relying only on reference information. The strongest drivers of the diet-induced changes are uncharacterized and previously undetected taxa, confirming the importance of adopting metagenomic methods integrating metagenomic assemblies for comprehensive profiling., The work was supported by the European Research Council (ERC-STG project MetaPG-716575 and ERC-CoG microTOUCH-101045015) to N.S. and ERC-CoG (project grant agreement no. 101001355) to O.K., by the European H2020 program (ONCOBIOME-825410 project and MASTER-818368 project) to N.S., by the National Cancer Institute of the National Institutes of Health (1U01CA230551) to N.S., by the Premio Internazionale Lombardia e Ricerca 2019 to N.S., by the European Research Council under the European Union’s Horizon 2020 Research and Innovation Programme (ERC-2016-StG-71577) to H.S., by VolkswagenStiftung’s initiative “Niedersächsisches Vorab” (grant no. 76251-99) to T.S, and by the European Research Council (CoG 865466) to T.S.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Large-scale metagenomic analysis of oral microbiomes reveals markers for autism spectrum disorders

  • Manghi, Paolo
  • Vallès Colomer, Mireia
  • Domenici, Enrico
The link between the oral microbiome and neurodevelopmental disorders remains a compelling hypothesis, still requiring confirmation in large-scale datasets. Leveraging over 7000 whole-genome sequenced salivary samples from 2025 US families with children diagnosed with autism spectrum disorders (ASD), our cross-sectional study shows that the oral microbiome composition can discriminate ASD subjects from neurotypical siblings (NTs, AUC = 0.66), with 108 differentiating species (q < 0.005). The relative abundance of these species is highly correlated with cognitive impairment as measured by Full-Scale Intelligence Quotient (IQ). ASD children with IQ < 70 also exhibit lower microbiome strain sharing with parents (p < 10-6) with respect to NTs. A two-pronged functional enrichment analysis suggests the contribution of enzymes from the serotonin, GABA, and dopamine degradation pathways to the distinct microbial community compositions observed between ASD and NT samples. Although measures of restrictive eating diet and proxies of oral hygiene show relatively minor effects on the microbiome composition, the observed associations with ASD and IQ may still represent unaccounted-for underlying differences in lifestyle among groups. While causal relationships could not be established, our study provides substantial support to the investigation of oral microbiome biomarkers in ASD., This work was supported by a grant from SFARI (Award 648614, E.D. and N.S.); by the European Research Council (ERC-STG project MetaPG-716575 and ERC-CoG project MicroTOUCH-101045015) to N.S.; by the European H2020 program (ONCOBIOME-825410 project and MASTER-818368 project) to N.S.; by the National Cancer Institute of the National Institutes of Health (1U01CA230551) to N.S.; by the Premio Internazionale Lombardia e Ricerca 2019 to N.S. We are grateful in particular to all of the families in SPARK, the SPARK clinical sites and SPARK staff. We appreciate obtaining access to the metagenomic raw data, the genetic data and the associated samples metadata on SFARI Base. The authors would like to thank Michael Whalen for his inspiring suggestion, which provided the starting point for this research. Approved researchers can obtain the SPARK population dataset described in this study (SFARI_SPARK_iWGS_v1.1) by applying at https://base.sfari.org.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Coffee consumption is associated with intestinal Lawsonibacter asaccharolyticus abundance and prevalence across multiple cohorts

  • Manghi, Paolo
  • Vallès Colomer, Mireia
  • Song, Mingyang
Although diet is a substantial determinant of the human gut microbiome, the interplay between specific foods and microbial community structure remains poorly understood. Coffee is a habitually consumed beverage with established metabolic and health benefits. We previously found that coffee is, among >150 items, the food showing the highest correlation with microbiome components. Here we conducted a multi-cohort, multi-omic analysis of US and UK populations with detailed dietary information from a total of 22,867 participants, which we then integrated with public data from 211 cohorts (N = 54,198). The link between coffee consumption and microbiome was highly reproducible across different populations (area under the curve of 0.89), largely driven by the presence and abundance of the species Lawsonibacter asaccharolyticus. Using in vitro experiments, we show that coffee can stimulate growth of L. asaccharolyticus. Plasma metabolomics on 438 samples identified several metabolites enriched among coffee consumers, with quinic acid and its potential derivatives associated with coffee and L. asaccharolyticus. This study reveals a metabolic link between a specific gut microorganism and a specific food item, providing a framework for the understanding of microbial dietary responses at the biochemical level., This work was supported by ZOE and TwinsUK, which is funded by the Wellcome Trust, Medical Research Council, Versus Arthritis, European Union Horizon 2020, Chronic Disease Research Foundation, the National Institute for Health Research Clinical Research Network and Biomedical Research Centre based at Guy’s and St Thomas’ NHS Foundation Trust in partnership with King’s College London. We acknowledge the support of the European Research Council (ERC-STG project MetaPG-716575 and ERC-CoG microTOUCH-101045015) to N.S., of the European Union’s Horizon 2020 programme (ONCOBIOME-825410 project, MASTER-818368 project and IHMCSA-964590) to N.S., of the MUR PNRR project INEST-Interconnected Nord-Est Innovation Ecosystem (ECS00000043) funded by the NextGenerationEU to N.S., and of the National Cancer Institute of the National Institutes of Health (1U01CA230551 to N.S. and U01CA261961 and R01CA263776 to M.S.) and of the Premio Internazionale Lombardia e Ricerca 2019 to N.S. The MBS and MLVS were supported by NIH U01CA176726 and U01CA167552. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Intestinal Blastocystis is linked to healthier diets and more favorable cardiometabolic outcomes in 56,989 individuals from 32 countries

  • Piperni, Elisa
  • Vallès Colomer, Mireia
  • Asnicar, Francesco
Diet impacts human health, influencing body adiposity and the risk of developing cardiometabolic diseases. The gut microbiome is a key player in the diet-health axis, but while its bacterial fraction is widely studied, the role of micro-eukaryotes, including Blastocystis, is underexplored. We performed a global-scale analysis on 56,989 metagenomes and showed that human Blastocystis exhibits distinct prevalence patterns linked to geography, lifestyle, and dietary habits. Blastocystis presence defined a specific bacterial signature and was positively associated with more favorable cardiometabolic profiles and negatively with obesity (p < 1e-16) and disorders linked to altered gut ecology (p < 1e-8). In a diet intervention study involving 1,124 individuals, improvements in dietary quality were linked to weight loss and increases in Blastocystis prevalence (p = 0.003) and abundance (p < 1e-7). Our findings suggest a potentially beneficial role for Blastocystis, which may help explain personalized host responses to diet and downstream disease etiopathogenesis., We thank the participants of the PREDICT program. This work was supported by Zoe Ltd. and TwinsUK, which are funded by the Wellcome Trust, Medical Research Council, Versus Arthritis, European Union Horizon 2020, Chronic Disease Research Foundation, the National Institute for Health Research Clinical Research Network, and the Biomedical Research Centre based at Guy’s and St Thomas’ NHS Foundation Trust in partnership with King’s College London. It was partially supported by the American Gastroenterological Association Research Foundation’s Research Scholars Award to L.H.N., the Crohn’s and Colitis Foundation Career Development Award to L.H.N., and NIH/NIDDK K23DK125838 to L.H.N. L.H.N. is the Massachusetts General Hospital/Chen Institute Transformative Scholar in Medicine. The study was supported by the European Research Council (ERC-STG project MetaPG-716575 and ERC-CoG microTOUCH-101045015) to N.S., by the European Union’s Horizon 2020 program (ONCOBIOME-825410 project, MASTER- 818368 project, and IHMCSA-964590) to N.S., by the European Union’s Horizon Europe program (DOMINO-101060218), by the European Union NextGenerationEU (INEST) to N.S., by the National Cancer Institute of the National Institutes of Health (1U01CA230551) to N.S. and R35 CA253178 to A.T.C., and by the Premio Internazionale Lombardia e Ricerca 2019 to N.S. The MBS and MLVS were supported by NIH U01CA176726 and U01CA167552. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The Lifelines Biobank initiative has been made possible by the Dutch Ministry of Health, Welfare, and Sport; the Dutch Ministry of Economic Affairs; the University Medical Center Groningen; the University of Groningen; and the Northern Provinces of the Netherlands. The authors acknowledge the services of the Lifelines Cohort Study, the contributing research centers delivering data to Lifelines, and all the study participants. J.F. is supported by the Dutch Heart Foundation IN-CONTROL (CVON2018-27), the ERC-CoG (No.101001678), NWO-VICI grant VI.C.202.022, the AMMODO Science Award 2023 for Biomedical Sciences from Stichting Ammodo, and the Netherlands Organ-on-Chip Initiative, an NWO Gravitation project (024.003.001) funded by the Ministry of Education, Culture, and Science of The Netherlands. A.Z. is supported by the Dutch Heart Foundation IN-CONTROL (CVON2018-27), the ERC-StG (No. 715772), NWO-VIDI grant 016.178.056, and the NWO Gravitation grant Exposome-NL (024.004.017). A.T.C. is partially supported by an American Cancer Society Research Professor Award.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Microbiome connections with host metabolism and habitual diet from 1,098 deeply phenotyped individuals

  • Asnicar, Francesco
  • Vallès Colomer, Mireia
  • Segata, Nicola
The gut microbiome is shaped by diet and influences host metabolism; however, these links are complex and can be unique to each individual. We performed deep metagenomic sequencing of 1,203 gut microbiomes from 1,098 individuals enrolled in the Personalised Responses to Dietary Composition Trial (PREDICT 1) study, whose detailed long-term diet information, as well as hundreds of fasting and same-meal postprandial cardiometabolic blood marker measurements were available. We found many significant associations between microbes and specific nutrients, foods, food groups and general dietary indices, which were driven especially by the presence and diversity of healthy and plant-based foods. Microbial biomarkers of obesity were reproducible across external publicly available cohorts and in agreement with circulating blood metabolites that are indicators of cardiovascular disease risk. While some microbes, such as Prevotella copri and Blastocystis spp., were indicators of favorable postprandial glucose metabolism, overall microbiome composition was predictive for a large panel of cardiometabolic blood markers including fasting and postprandial glycemic, lipemic and inflammatory indices. The panel of intestinal species associated with healthy dietary habits overlapped with those associated with favorable cardiometabolic and postprandial markers, indicating that our large-scale resource can potentially stratify the gut microbiome into generalizable health levels in individuals without clinically manifest disease., This work was supported by Zoe Global and received support from grants from the Wellcome Trust (no. 212904/Z/18/Z) and Medical Research Council/British Heart Foundation Ancestry and Biological Informative Markers for Stratification of Hypertension (no. MR/M016560/1). The work was also supported by the European Research Council (ERC-STG project MetaPG-716575 to N.S.), MIUR ‘Futuro in Ricerca’ (grant no. RBFR13EWWI_001 to N.S.), the European H2020 program (ONCOBIOME-825410 and MASTER-818368 projects to N.S.), the National Cancer Institute of the National Institutes of Health (grant no. 1U01CA230551 to N.S.) and the Premio Internazionale Lombardia e Ricerca 2019 to N.S. S.E.B. was supported in part by a grant funded by the Biotechnology and Biological Sciences Research Council (grant no. BB/NO12739/1). P.W.F. was supported in part by grants from the European Research Council (grant no. CoG-2015_681742_NASCENT), Swedish Research Council (grant no. IRC15-0067) and Novo Nordisk Foundation. A.T.C. was supported in part as a Stuart and Suzanne Steele MGH Research Scholar. TwinsUK is funded by the Wellcome Trust, Medical Research Council, European Union, Chronic Disease Research Foundation, Zoe Global and the National Institute for Health Research-funded BioResource, Clinical Research Facility and Biomedical Research Centre based at Guy’s and St Thomas’ NHS Foundation Trust in partnership with King’s College London.